PRESTIGE CONSUMER HEALTHCARE INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 1.80 million shares for the 1-month period ending 2014-06-30, per its 10-Q filed 2017-02-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2017-02-02
- 2014-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month 1.80M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 1 month |
|---|---|
| 2014-06-30 | 1.80M shares 10-Q · filed 2017-02-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |